2022
DOI: 10.1016/j.xpro.2022.101807
|View full text |Cite
|
Sign up to set email alerts
|

Neural circuit-specific gene manipulation in mouse brain in vivo using split-intein-mediated split-Cre system

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
6
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
3
2

Relationship

2
3

Authors

Journals

citations
Cited by 5 publications
(6 citation statements)
references
References 20 publications
0
6
0
Order By: Relevance
“…These include rAAV2/1-hSyn- Cre , rAAV2.retro-hSyn- Cre , rAAV2/1-Ef1α- CreN-InteinN , rAAV2.retro-Ef1α- InteinC-CreC , rAAV2/8-Ef1α- CreN-InteinN , and rAAV2/9-Syn -Flex-jGCaMP8m . The production and subsequent titer measurement of these rAAVs were based on protocols from our previous studies 38, 60 , with necessary adjustments. Notably, to produce rAAV2/1-Ef1α- CreN-InteinN and rAAV2/1-hSyn- Cre , we utilized the pAAV2/1 packaging plasmid (Addgene #112862), diverging from our previous use of the pAAV 2/8 or 2/9 plasmids.…”
Section: Methodsmentioning
confidence: 99%
See 3 more Smart Citations
“…These include rAAV2/1-hSyn- Cre , rAAV2.retro-hSyn- Cre , rAAV2/1-Ef1α- CreN-InteinN , rAAV2.retro-Ef1α- InteinC-CreC , rAAV2/8-Ef1α- CreN-InteinN , and rAAV2/9-Syn -Flex-jGCaMP8m . The production and subsequent titer measurement of these rAAVs were based on protocols from our previous studies 38, 60 , with necessary adjustments. Notably, to produce rAAV2/1-Ef1α- CreN-InteinN and rAAV2/1-hSyn- Cre , we utilized the pAAV2/1 packaging plasmid (Addgene #112862), diverging from our previous use of the pAAV 2/8 or 2/9 plasmids.…”
Section: Methodsmentioning
confidence: 99%
“…Stereotaxic surgeries for viral injections were conducted in accordance with the protocols established in our previous studies 37, 38 . Briefly, mice aged 8-10 weeks were anesthetized using an isoflurane vaporizer (VetEquip).…”
Section: Methodsmentioning
confidence: 99%
See 2 more Smart Citations
“…To produce AAV-PHP.v1-CLDN5-GSK3β S9A -HA and AAV-PHP.v1-CLDN5-HA, HEK293T cells were co-transfected with pAdDeltaF6, pUCmini-iCAP-PHP.V1 plasmid, and AAV-CLDN5-GSK3β S9A -HA or AAV-CLDN5-HA plasmid expressing GSK3β S9A -HA or HA under control of CLDN5 promoter. AAV puri cation was performed as previously described 23,24,60,61 . After 72 h incubation, HEK293T cells were collected and lysed with lysis buffer [20 mM Tris-HCl (pH8.5), 150 mM NaCl] through four times of freeze-thaw process in dry ice/ethanol bath and 37 °C water bath.…”
Section: Aav Production and Titrationmentioning
confidence: 99%